Navigation Links
Primus Innovations and Health Robotics Launch Strategic Partnership to Accelerate Transformation in Chemotherapy Compounding
Date:11/12/2007

Shared vision for improving patient and staff safety and minimizing waste

of pharmaceuticals.

FRISCO, Texas, Nov. 12 /PRNewswire/ -- The convergence of a world-class sales and service organization and a manufacturing organization will allow both companies to drive new growth opportunities and ultimately transform the way cancer fighting drugs are prepared and administered. The combination of Primus Innovations, Inc. solutions, sales, and services with Health Robotics engineering, software and robotic chemotherapy compounding technology "CytoCare(TM)", will enable a new standard of precision, accuracy, safety, and price efficiencies in chemotherapy admixtures.

Jack Risenhoover, Health Robotics Managing Principal, described the trampoline effect of the combination as a "powerful tool in the battle against cancer. We are particularly pleased that Primus Innovations has selected CytoCare as its exclusive solution for chemotherapy compounding for hospitals and outpatient infusion centers. Primus' experience in outsourcing will be a significant advantage for CytoCare customers."

Steve Bohannon, Primus Innovations, Inc. CEO and President, said, "Health Robotics has designed an incredible product that tilts the scales in the battle against cancer. In CytoCare we have a rare triple win: more accurate infusions for patients, a far safer environment for pharmacists and technicians and better economics and regulatory compliance for hospitals, clinics and physicians. We are incredibly pleased to be the exclusive distributor and service provider for CytoCare in North America."

CytoCare provides unparalleled benefits for patients, staff and pharmacists. The sterile robotic environment minimizes manual interaction and the associated risk of contamination. It supports patient-specific dosing, by using the patient's unique physical profile. Thus, the medication regimen is tailored and accurate with swifter, more effective results.

Moreover, dosing accuracy is enhanced with multiple and redundant safety checks further protecting the patient from potential medication errors. There are several hundred discrete data elements of the preparation process that are automatically tracked and saved as part of the permanent electronic medical record. To address USP 797 and other regulatory standards CytoCare provides an audit trail for record keeping purposes. CytoCare generates significant, immediate savings through FTE savings, reduction of redundant components from closed transfer devices, and efficiently using partial drug vials with automated time/date stamps and beyond use expiration alerts based on user defined protocols.

Primus Innovations and Health Robotics will be showcasing the CytoCare robot at the ASHP 42nd Annual Mid Year clinical meeting and exhibition in Las Vegas December 2-6th at booth #2644.

Primus Innovations, Inc., located in Frisco, Texas is the pre-eminent provider of automation, technology and services to the Oncology Industry. Primus is a strategic business partner to its customers offering a full suite of professional services encompassing all of the elements of support and outsourcing that our customers may require allowing them to focus on their core business. Primus also provides flexible financing programs which are designed to meet their customer economic requirements. For more information please visit: http://www.primusinnovations.com

About Health Robotics:

Health Robotics is the worldwide leader in patient specific, robotic chemotherapy admixtures. Its advanced technology and innovative engineering enhances sterility, delivers accurate doses for patients and helps protect clinicians from exposure to cytotoxic agents that can occur during manual compounding. http://www.healthrobotics.net


'/>"/>
SOURCE Primus Innovations, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Access Innovations Provides Support Services for Agis Network
2. Small Bone Innovations Introduces the Artelon(R) STT Spacer to Increase Treatment Options for Thumb Arthritis
3. Prize for Cutting-Edge Laser Innovations
4. Health Literacy Innovations Releases New Survey on Medicaid Health Literacy Standards
5. Cleveland Clinic Unveils Top 10 Medical Innovations For 2008
6. Inverness Medical Innovations Acquires Bio-Stat Healthcare Group
7. Lumenis(R) Introduces the Newest Innovations in Fractional CO2 Laser Skin Therapy
8. Young Innovations, Inc. Provides Third Quarter Conference Call Details
9. Fenwal Signs Development, Distribution and Licensing Agreement With Data Innovations, Inc.
10. Young Innovations, Inc. Announces Results for the Third Quarter Ended September 30, 2007 and Declares Quarterly Dividend
11. SPOC, Inc. announces completion of $300,000 follow-on investment by Connecticut Innovations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... ... 2016 , ... Psoriasis: Targets and Therapy has ... corresponding author Professor Luigi Naldi says “The review in Psoriasis: Targets and Therapy ... the onset and the severity of psoriasis, and negatively influences the response to ...
(Date:5/31/2016)... ... May 31, 2016 , ... More than 80 representatives of the ... and the Prevent Cancer Foundation held an event on National Hepatitis Testing Day outside ... of viral hepatitis, the leading cause of liver cancer. , Foundation leaders and the ...
(Date:5/31/2016)... ... ... Twenty years ago it was revolutionary: enabling the people who hear distressing voices to ... this approach has proven transformative, both for people who hear voices and for the ... used around the world, but it still lags in the United States. , Now, ...
(Date:5/31/2016)... , ... May 31, 2016 , ... ... calls back to particular advertising campaigns, to monitor the performance of sales and ... can maximize conversions and revenue. The software allows customers to record, transcribe, route, ...
(Date:5/31/2016)... ... May 31, 2016 , ... Like jewels in a crown, the multiple awards ... is home to Ontario’s leading day spa and one of Canada’s few accredited 5 ... a unique concept to combine spa services with hair and beauty services ...
Breaking Medicine News(10 mins):
(Date:5/30/2016)... 30, 2016 According ... Biometrics Market by Technology (Single-factor (Fingerprint, Face, ... Application (Workforce Management), End User (Hospitals, Healthcare ... by MarketsandMarkets, the market is projected to ... USD 1,182.6 Million by 2016, at a ...
(Date:5/30/2016)... - DCGI grants limited approval to market Stempeucel® product for ... Stempeucel® becomes 5th off-the-shelf Stem cell product to be approved by ... Disease (also known as Thromboangiitis Obliterans) is a major unmet medical ... - Prevalence of Buerger,s Disease is estimated to be 1,000,000 in ... the European Community & USA ...
(Date:5/27/2016)... LabStyle Innovations Corp . ( ... today announced that the Company,s Chief Financial Officer, Zvi ... held June 1-2 in New York, NY ... in Los Angeles, CA. ... operational milestones, including the U.S. FDA Clearance and commercial launch ...
Breaking Medicine Technology: